Lilly commences Phase III trial of baricitinib to treat Covid-19 - Clinical Trials Arena 17-Jun-2020

Lilly commences Phase III trial of baricitinib to treat Covid-19 - Clinical Trials Arena

Eli Lilly has started patient enrolment for a Phase III clinical trial of baricitinib to treat adults hospitalised due to Covid-19 infection.

More...